MAS1 and pulmonary arterial hypertension: Another method to counter the vasoconstrictive and proliferative ACE/angiotensin II/AT1 receptor axis in PAH was demonstrated by activating the vasoprotective ACE2/Angiotensin-(1–7)/Mas axis of the RAAS.